Investigations of statins in heart failure: inflammatory biomarkers and hormones

Heart Failure Clinics
Bobby V Khan, Sanjay Rajagopalan

Abstract

The primary role of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) is to treat dyslipidemia. The clinical benefits with statin therapy have been demonstrated in the primary and secondary prevention of atherosclerotic vascular diseases. More recently, it has been observed that pleiotropic effects of statins (which may or may not be associated with lipid lowering) have been described as treatment of various cardiovascular disease processes and in noncardiac disease processes. This article evaluates the potential mechanisms for these effects in the management of heart failure and postulates their clinical and beneficial use.

References

Aug 12, 1999·Journal of Cardiovascular Pharmacology·F Follath
Nov 5, 1999·Cardiology·K KanekoR Nagai
Oct 19, 2000·Lancet·M RauchhausS D Anker
Jan 11, 2001·Journal of Cardiovascular Pharmacology and Therapeutics·W MärzH G Olbrich
Jan 17, 2002·Mayo Clinic Proceedings·Brian M Curtis, James H O'Keefe
Oct 16, 2002·Circulation·David J Lefer
Oct 25, 2002·Journal of Cardiac Failure·Tamara B HorwichGregg C Fonarow
Apr 16, 2003·Circulation·Rainer U PliquettIrving H Zucker
Dec 10, 2003·Journal of the American College of Cardiology·Mathias RauchhausStefan D Anker
Feb 14, 2004·Zeitschrift für Kardiologie·U LaufsG Nickenig
Apr 28, 2004·The American Journal of Cardiology·Dariush MozaffarianWayne C Levy
Feb 22, 2005·Atherosclerosis·Christopher H StreyChristopher M Frampton
Apr 6, 2005·Circulation·Ralph A H StewartUNKNOWN Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study Investigators
Dec 13, 2005·Nature Reviews. Drug Discovery·Mukesh K Jain, Paul M Ridker
Aug 17, 2006·Journal of Cardiac Failure·Stephen SanderC Michael White
Mar 24, 2007·Nature Clinical Practice. Cardiovascular Medicine·Michael J LipinskiGeorge W Vetrovec
Jan 5, 2008·International Journal of Clinical Practice·G Jackson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.